Christopher R. Haake

Spatial Biology Specialist with expertise in spatial proteomics, light-sheet microscopy, tissue clearing, and capital equipment sales. Experienced in developing emerging markets, partnering with scientific leaders, and guiding complex research organizations through technology evaluation and adoption. Combines deep scientific knowledge with strategic business development, territory planning, and executive-level relationship management

• Advanced capital equipment opportunities through targeted outreach, fostering key partnerships.
• Developed sales territory and pipeline strategies, resulting in expanded market reach.
• Generated interest through seminars, workshops, and product demonstrations, leading to increased engagement.
• Cross-functional coordination with applications, marketing, and sales teams
• Customer applications spanning spatial proteomics, tissue clearing, and light-sheet imaging
• Revenue, pipeline value, conversion rates, or growth wherever those figures are available

• Led a team effort to promote the sales of multi-omic early cancer detection, resulting in annual growth of $2M in FY2023.
• Executed commercial launch of xMAP SARS CoV-2 Multi-Antigen IgG Assay (EUA), resulting in 325% growth of assay sales.
• Successful global commercial launch of next-generation biomarkers discovery Instrumentation, xMAP INTELLIFLEX.
• Led systems and assay marketing strategy through cross-functional collaboration, event planning, and management of partner and distributor relationships to enhance market presence.
• Led the strategic direction in the cell and gene therapy market, successfully executed the plan, and fostered valuable collaborations with partners.
• Collaborated with Global Marketing team to shape instrument portfolio development, refine product offerings, and launch new products while managing strategies for product end-of-life.
• Played a pivotal role in establishing the LuminexPLORE Lab, facilitating assay development services for Pharma and CRO, and driving an impressive 30% year-over-year growth in the targeted market segment.
• Chaired Transplant Diagnostics Advisory Board meetings to drive strategic discussions and recommendations in 2020, 2021, and 2023.
• Recognized for outstanding performance with the Platinum Presidents' Club Award in 2019, 2020, 2021.

• Directed regional sales operations for multiplexing protein and gene expression instrumentation and consumables, leading marketing and sales strategy, business development, account management, presentations, negotiations, and client relationship management.
• Utilized consultative selling techniques to gain in-depth knowledge of clients' personnel, responsibilities, budgeting, forecasting, products, market, and competitors to tailor solutions effectively.
• Established a business plan to generate revenue through assay development and commercialization, attracting new clients and expanding client base.
• Received the Presidents' Club Award in 2017 and 2018 for outstanding performance.

• Spearheaded strategic sales operations for automated nucleic acid purification platforms, detection, and all qPCR instrumentation across the central region, including process improvement, event planning, and product launches and promotions.
• Promoted and sold automated nucleic acid purification platforms and qPCR instrumentation in central region, driving market penetration and customer adoption.
• Developed strategic partnerships with Ingenuity leaders to create and deliver co-branded educational symposiums, enhancing product visibility and engagement.
• Coordinated logistics for NGS pre-analytical workflow evaluations at regional beta test sites to ensure effective implementation.

• Delivered technical presentations and seminars to distribution partners and clients on RT-PCR, automation, detection, and PCR platforms.
• Led promotions and sales for automation, spectrophotometry, and real time-PCR products across Texas, Oklahoma, Arkansas, and Louisiana, focusing on strategy development, cross-functional collaboration, and training.
• Developed and executed strategic sales plans, achieving the most significant number of conversions within the next-generation sequencing market segment.
• Collaborated with marketing to launch 5073 platform featuring nucleic acid purification consumables.
• Recognized for outstanding performance with the Presidents' Club Award in 2011, 2012, and 2013 with 123% to plan in FY13.
• Additional experience includes Field Product Specialist with VWR International SP, Account Manager with Bayer Diagnostics, and Technical Sales Representative with Remel, Inc.